ЕLECTROPHILIC SUBSTITUTION IN 6,8-DIARYL-1Н-IMIDAZO[1,2-a]PYRIDINIUM SALTS

UDC 547.821+ 547.781

Authors

Keywords:

sulfonation, bromination, 1H-imidazo[1,2-a]pyridin-4-ium cation, 3-sulfoimidazo[1,2-a]pyridin, 3-bromoimidazo[1,2-a]pyridin

Abstract

Imidazo[1,2-a]pyridine moieties have attracted much recent interest because of their broad range of pharmacological activities. Electrophilic substitution is increasingly used in recent years as a method of modifying their structure. This paper studied electrophilic substitution in the 1H-imidazo[1,2-a]pyridin-4-ium cation. Sulfonation and bromination reactions were investigated for imidazo[1,2-a]pyridinium derivatives with an aryl groups substituted at the pyridine cycle. We cjnfirmed that the main direction of electrophilic substitution in 1-alkyl-1H-imidazo[1,2-a]pyridin-4-ium cation, as in unsubstituted in position 1 derivatives, is position 3. The formation of substitution product on phenyl groups of the molecule is possible in the presence of unsubstituted in 4 position phenyl groups.
The treatment of 6,8-bis(4-clorophenyl)-1-methyl-1H-imidazo[1,2-a]pyridin-4-ium bromide with HSO3Cl or H2SO4(c) gave 6,8-bis(4-clorophenyl)-1-methyl-3-sulfo-1H-imidazo[1,2-a]pyridin-4-ium halogenides. These results are similar to those for the reactions of 6,8-diaryl-1-methyl-1H-imidazo[1,2-a]pyridin-4-ium bromides with Br2 in AcOH, which gave 3-bromo-6,8-diaryl-1-methyl-1H-imidazo[1,2-a]pyridin-4-ium bromideses. However, the treatment of 6,8-diphenyl-1-methyl-1H-imidazo[1,2-a]pyridin-4-ium bromide with HSO3Cl provided a mixture of 1-methyl-6-phenyl-8-(4-sulfophenyl)-1H-imidazo[1,2-a]pyridin-4-ium and 1-methyl-6,8-diphenyl-3-sulfo-1H-imidazo[1,2-a]pyridin-4-ium halohenides (4 : 1) that could not be separated. 
The structure of products is proved by two-dimensional correlation spectroscopy NMR methods (COSY, NOESY, HMQC, HMBC).

References

1. Gudmundsson K.S., Williams J.D., Drach J.C., Townsend L.B. J. Med. Chem., 2003, 46(8), 1449–1455.

2. Beeswick P.J., Campbell I.B., Naylor A. World Patent Application WO 9631509.

3. Holm K.J., Goa K.L. Drugs, 2000, 59 (4), 865–889.

4. Zhuang Z.P., Kung M.P., Wilson A., Lee C.W., Plossl K., Hou C., Holtzman D.M., Kung H.F. J. Med. Chem., 2003, 46 (2), 237–243.

5. Abe Y., Kayakiri H., Satoh S., Inoue T., Sawada Y., Imai K.H. J. Med. Chem., 1998, 41 (4), 564–578.

6. Ishikawa T., Iizawa Y., Okonogi K., Miyake A. J. Antibiotics, 2000, 53 (10), 1053–1070.

7. Senn-Bilfinger J. US Patent 5824687, U.S.A., 1998.

8. Kishimoto S., Tomimatsu K., Miyake A., Yoshimura Y. US Patent 4921851, U.S.A., 1990.

9. Kaiser C., Spagnuolo C.J., Adams Jr. T.S., Audia V.H., Dupont A.C., Hatoum H., Lowe V.C., Prosser J.C., Sturm B.L., Noronha-Blob L. J. Med. Chem., 1992, 35 (23), 4415–4424.

10. Patnaik S., Marugan J.J., Liu K., Zheng W., Southall N., Dehdashti S.J., Thorsell A., Heilig M., Bell L., Zook M., Eskay B., Brimacombe K.R., Austin C.P. J. Med. Chem., 2013, 56 (22), 9045–9056.

11. Ikemoto T., Wakimasu M. Heterocycles, 2001, 55 (1), 99–108.

12. Mondal S., Samanta S., Singsardar M., Mishra S., Mitra S., Hajra A. Synthesis, 2016, 48 (22), 4009–4015.

13. Castera-Ducros C., El-Kashef H., Piednoël M., Remusat V., Teulade J.-C., Verhaeghe P., Rathelot P., Vanelle P. Lett. Org. Chem., 2016, 13 (7), 519–525.

14. Ma Y., Sun G., Chen D., Peng X., Chen Y.-L., Su Y., Ji Y., Liang J., Wang X., Chen L., Ding J., Xiong B., Ai J., Geng M., Shen J. J. Med. Chem., 2015, 58 (5), 2513–2529.

15. Li C., Ai J., Zhang D., Peng X., Chen X., Gao Z., Su Y., Zhu W., Ji Y., Chen X., Geng M., Liu H. ACS Med. Chem. Lett., 2015, 6 (5), 507–512.

16. Damour D., Nemecek C., Nemecek P., Wentzler S. US Patent 2011/257171, U.S.A., 2011.

17. Ельцов А.В., Мартынова В.П., Захс Э.Р., Шустова Л.П. Журн. орг. химии, 1974, 10 (11), 2467.

El'tsov A.V., Martynova V.P., Zachs E.R., Shustova L.P. Zhurnal Organicheskoi Khimii, 1974, 10 (11), 2467 (in Russian).

18. Edward J.T., Whiting J. Can. J. Chem., 1971, 49, 3502–3514.

19. Potikha L., Kovtunenko V., Turelyk A., Turov A., Tolmachev A. Synth. Commun., 2008, 38 (12), 2061–2070.

20. Potikha L.M., Kovtunenko V.A., Turelyk A.R., Тurov А.V. Chem. Heterocycl. Comp., 2010, 46 (1), 82–95.

Published

2017-05-25

How to Cite

ЕLECTROPHILIC SUBSTITUTION IN 6,8-DIARYL-1Н-IMIDAZO[1,2-a]PYRIDINIUM SALTS: UDC 547.821+ 547.781. (2017). Bulletin of the Taras Shevchenko National University of Kyiv. Chemistry, 53(1), 16-18. https://chemistry.bulletin.knu.ua/article/view/8572

Most read articles by the same author(s)